AQR Capital Management
CABA icon

AQR Capital Management’s Cabaletta Bio CABA Stock Holding History

AQR Capital Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-32,129
Closed -$48.8K – 3481
2025
Q2 		$48.8K Sell
32,129
-41,827
-57% -$65.2K ﹤0.01% 3239
2025
Q1 		$102K Buy
+73,956
New +$158K ﹤0.01% 3012
2024
Q2 		– Sell
-12,311
Closed -$210K – 2610
2024
Q1 		$210K Sell
12,311
-1,450
-11% -$31.1K ﹤0.01% 2243
2023
Q4 		$312K Sell
13,761
-785
-5% -$13.2K ﹤0.01% 2051
2023
Q3 		$221K Buy
+14,546
New +$199K ﹤0.01% 2113

Other funds holding CABA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return

AQR Capital Management's CABA Position: Q3 2025 in Review

AQR Capital Management sold out of Cabaletta Bio (CABA) in Q3 2025, closing a stake of 32,129 shares — an estimated $48.8K sold.

AQR Capital Management first reported a position in CABA in Q3 2023 and held it in 5 quarters. The position peaked at $312K in Q4 2023. 75 funds tracked by Wall St. Rank hold CABA as of Q3 2025.

  • AQR Capital Management reported no remaining Cabaletta Bio position as of Q3 2025 after selling out during the quarter.
  • AQR Capital Management sold 32,129 Cabaletta Bio shares in Q3 2025, an estimated $48.8K.
  • AQR Capital Management first reported a position in Cabaletta Bio in Q3 2023 and held it in 5 quarters.
  • AQR Capital Management's Cabaletta Bio position peaked at $312K in Q4 2023.
  • 75 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2025.

Based on AQR Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.